Table of Contents Table of Contents
Previous Page  94 / 94
Information
Show Menu
Previous Page 94 / 94
Page Background NCCN.org/patients – For Patients

|

NCCN.org – For Clinicians

NCCN Foundation

®

gratefully acknowledges Amgen, Inc. and Pfizer, Inc. for their support in making available these NCCN Guidelines for

Patients

®

. NCCN independently develops and distributes the NCCN Guidelines for Patients. Our industry supporters do not participate in

the development of the NCCN Guidelines for Patients and are not responsible for the content and recommendations contained therein.

PAT-N-1000-0717

Acute Lymphoblastic

Leukemia

Version 1.2017

275 Commerce Drive

Suite 300

Fort Washington, PA 19034

215.690.0300

NCCN

GUIDELINES

FOR PATIENTS

®